Leading Diabetes Organizations Issue Consensus Statement Defining Health Outcomes Beyond HbA1c
November 22, 2017
November 22, 2017
NEW YORK, Nov. 22 -- JDRF, charitable 501(c)(3) organization dedicated to funding type 1 diabetes research, issued the following news release:
A committee representing leading U.S. diabetes clinical and research organizations has issued a consensus statement that identifies and defines clinically meaningful type 1 diabetes (T1D) outcomes beyond hemoglobin HbA1c (A1c). The Steering Committee for the Type 1 Diabetes Outcomes Program, organized by JDRF, released the consensus statement . . .
A committee representing leading U.S. diabetes clinical and research organizations has issued a consensus statement that identifies and defines clinically meaningful type 1 diabetes (T1D) outcomes beyond hemoglobin HbA1c (A1c). The Steering Committee for the Type 1 Diabetes Outcomes Program, organized by JDRF, released the consensus statement . . .